InsiderClue
← All stocks

Monte Rosa Therapeutics, Inc.

GLUE Net buying
CIK 0001826457 #2381 in the set updated 19 Sep 2026
Bought (120 mo)
$276.81M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$16.42M
$436.05K on a plan · $2.68M straight out of an exercise
Sold at will
$13.31M
21 of 46 sales
Net
+$260.39M
+$263.50M against sales at will

By person

25 insiders · 63 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
BASKETT FOREST
10% owner
$19.95M (1)
—
+$19.95M
7,692,298
9.02%
$178.31M
—
Behbahani Ali
Director
$19.95M (1)
—
+$19.95M
7,692,298
9.02%
$178.31M
+669.2%
Chang Carmen
10% owner
$19.95M (1)
—
+$19.95M
7,692,298
9.02%
$178.31M
—
Florence Anthony A. Jr.
10% owner
$19.95M (1)
—
+$19.95M
7,692,298
9.02%
$178.31M
—
Landsman Liza
10% owner
$19.95M (1)
—
+$19.95M
7,692,298
9.02%
$178.31M
—
Makhzoumi Mohamad
10% owner
$19.95M (1)
—
+$19.95M
7,692,298
9.02%
$178.31M
—
MAKOWER JOSHUA
10% owner
$19.95M (1)
—
+$19.95M
7,692,298
9.02%
$178.31M
—
Mathers Edward T
10% owner
$19.95M (1)
—
+$19.95M
7,692,298
9.02%
$178.31M
—
New Enterprise Associates 17, L.P. entity
10% owner
$19.95M (1)
—
+$19.95M
7,692,298
9.02%
$178.31M
—
SANDELL SCOTT D
10% owner
$19.95M (1)
—
+$19.95M
7,692,298
9.02%
$178.31M
—
Sonsini Peter W.
10% owner
$19.95M (1)
—
+$19.95M
7,692,298
9.02%
$178.31M
—
Walker Paul Edward
10% owner
$19.95M (1)
—
+$19.95M
7,692,298
9.02%
$178.31M
—
Yang Rick
10% owner
$19.95M (1)
—
+$19.95M
7,692,298
9.02%
$178.31M
—
Cormorant Asset Management, LP entity
Former 10% Owner
$11.40M (1)
—
+$11.40M
3,202,200
3.75%
$74.23M
—
Versant Venture Capital VI, L.P. entity
10% owner
$3.00M (1)
$12.29M (7)
−$9.29M
7,750,860
9.09%
$179.67M
+225.5%
Bolzon Bradley J PhD
Director
$3.00M (1)
—
+$3.00M
8,897,053
10.43%
$206.24M
+3,041%
Janku Filip
Chief Medical Officer
—
$1.38M (6) scheduled
−$1.38M
60,612
0.0710%
$1.41M
+413.6%
Warmuth Markus
President & CEO
—
$951.14K (10)
−$951.14K
585,038
0.6858%
$13.56M
+40.5%
Dunn Edmund
Principal Accounting Officer
—
$503.36K (7) scheduled
−$503.36K
22,554
0.0264%
$522.82K
+34.6%
Townson Sharon
Chief Scientific Officer
—
$423.93K (6) scheduled
−$423.93K
67,845
0.0795%
$1.57M
—
Manning Anthony M.
Director
—
$411.20K (2) scheduled
−$411.20K
0
0.0000%
$0.00
—
Champoux Jennifer
Chief Operating Officer
—
$311.30K (6) scheduled
−$311.30K
62,371
0.0731%
$1.45M
—
Nickson Philip
Chief Business & Legal Officer
—
$151.27K (2)
−$151.27K
55,000
0.0645%
$1.27M
—
Leo Chandra P.
Director
$58.38K (1)
—
+$58.38K
10,000
0.0117%
$231.81K
—
Bowen Matthew
Principal Accounting Officer
—
—
—
25,904
0.0304%
$600.48K
+19.9%

Individual transactions

18
Insider
Date
Role
Action
Shares
Price
Amount
Champoux Jennifer
15 Jul 2026
Chief Operating Officer
Sold after exercise
4,351
$23.38
$101.73K
Townson Sharon
6 Jul 2026
Chief Scientific Officer
Sold after exercise
400
$24.13
$9.65K
Townson Sharon
6 Jul 2026
Chief Scientific Officer
Sold after exercise
5,600
$23.25
$130.20K
Janku Filip
30 Jun 2026
Chief Medical Officer
Sold after exercise
5,407
$24.50
$132.47K
Manning Anthony M.
29 Jun 2026
Director
Sold after exercise
10,000
$23.11
$231.10K
Janku Filip
29 Jun 2026
Chief Medical Officer
Sold after exercise
6,000
$22.95
$137.70K
Janku Filip
24 Jun 2026
Chief Medical Officer
Sold after exercise
30,000
$21.42
$642.68K
Townson Sharon
23 Jun 2026
Chief Scientific Officer
Sold after exercise
3,000
$20.00
$60.00K
Champoux Jennifer
23 Jun 2026
Chief Operating Officer
Sold after exercise
2,175
$20.00
$43.50K
Janku Filip
23 Jun 2026
Chief Medical Officer
Sold after exercise
11,845
$20.22
$239.52K
Townson Sharon
17 Jun 2026
Chief Scientific Officer
Sold after exercise
3,000
$19.00
$57.00K
Champoux Jennifer
17 Jun 2026
Chief Operating Officer
Sold after exercise
2,176
$19.00
$41.34K
Townson Sharon
29 May 2026
Chief Scientific Officer
Sold after exercise
6,000
$19.87
$119.22K
Champoux Jennifer
27 May 2026
Chief Operating Officer
Sold after exercise
2,175
$20.00
$43.50K
Champoux Jennifer
22 May 2026
Chief Operating Officer
Sold after exercise
2,176
$19.00
$41.34K
Manning Anthony M.
21 May 2026
Director
Sold after exercise
10,000
$18.01
$180.10K
Dunn Edmund
2 Mar 2026
Principal Accounting Officer
Sold after exercise
536
$17.50
$9.38K
Dunn Edmund
27 Feb 2026
Principal Accounting Officer
Sold after exercise
25,164
$18.10
$455.51K
Show all 63 transactions →

What was left out

Form 4 filings counted 134
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 18
Sales at will 21
Transactions with no price 0
Shares from compensation/vesting 109,003,555
History held since 25 Jun 2021